1
|
Tran C, Mahé E, Beylot-Barry M, Jullien D, Richard MA, Fougerousse AC, Bouznad A, Bulai Livideanu C, Brun A, Amelot F, Maccari F, Aubin F, Benhadou F, Paul C. Real-life management of psoriasis with biological agents during pregnancy. Ann Dermatol Venereol 2024; 151:103254. [PMID: 38554588 DOI: 10.1016/j.annder.2024.103254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 11/07/2023] [Indexed: 04/01/2024]
Abstract
BACKGROUND French guidelines recommend stopping biologic treatment of psoriasis between 3 and 24 weeks before conception in accordance with the relevant Summary of Product Characteristics (SmPC). The aim of this study was to evaluate the real-life practice of dermatologists in the management of pregnant women with psoriasis previously treated with biologic agents. We wished to assess the level of practitioner adherence to the relevant SmPCs. MATERIAL AND METHODS We conducted a study in collaboration with GRPso and Resopso. A computerized questionnaire was completed by the practitioners. We performed descriptive statistics and studied the profile of the practitioners, their level of confidence with continuation of biological agents during pregnancy, and their reported practices on the use of biological agents in pregnancy. Statistical analyses were performed using XLSTAT. A p-value of less than 0.05 was considered significant. RESULTS A total of 63 dermatologists (women: 71%; mean age 43.8 years) participated in this study, the majority of whom were hospital-based (87%). Recommendations were followed by 36.5% of practitioners, while 44% reported discontinuing biologic agents on diagnosis of pregnancy, and 20.5% reported using these agents during pregnancy. Among dermatologists with more than ten years of experience, 19% reported following the SmPC. Among dermatologists with a patient base >200 (patients treated with biologic agents for psoriasis), 19% reported following the SmPC compared to 54% of practitioners with less than 50 patients. The mean age of dermatologists following the SmPC was 41 years vs. 47 years for those not following the SmPC. DISCUSSION The majority of practitioners do not follow recommendations on discontinuation of biologic agents before the planning of pregnancy by patients.
Collapse
Affiliation(s)
- C Tran
- Department of Dermatology, Toulouse University Hospital, 31400 Toulouse, France
| | - E Mahé
- Department of Dermatology, Victor Dupouy Hospital, 95107 Argenteuil, France; Groupe d'Etudes Multicentriques (GEM) Resopso, France; GRPso (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), France
| | - M Beylot-Barry
- Department of Dermatology, Bordeaux University Hospital, 33000 Bordeaux, France; GRPso (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), France
| | - D Jullien
- Department of Dermatology, Lyon University Hospital, 69003 Lyon, France; GRPso (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), France
| | - M-A Richard
- Department of Dermatology, Marseille University Hospital, 13005 Marseille, France; GRPso (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), France
| | - A-C Fougerousse
- Department of Dermatology, Hôpital d'Instruction des Armées Bégin, France; Groupe d'Etudes Multicentriques (GEM) Resopso, France
| | - A Bouznad
- Department of Dermatology, Toulouse University Hospital, 31400 Toulouse, France
| | - C Bulai Livideanu
- Department of Dermatology, Toulouse University Hospital, 31400 Toulouse, France; Groupe d'Etudes Multicentriques (GEM) Resopso, France
| | - A Brun
- Department of Dermatology, Toulouse University Hospital, 31400 Toulouse, France
| | - F Amelot
- Department of Dermatology, Carcassonne Hospital, 11000 Carcassonne, France
| | - F Maccari
- Department of Dermatology, Hôpital d'Instruction des Armées Bégin, France; Groupe d'Etudes Multicentriques (GEM) Resopso, France
| | - F Aubin
- Department of Dermatology, Besançon University Hospital, 25000 Besançon, France; GRPso (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), France
| | - F Benhadou
- Department of Dermatology, Erasme Hôpital universitaire, Université Libre de Bruxelles, 1070 Brussels, Belgium; Groupe d'Etudes Multicentriques (GEM) Resopso, France
| | - C Paul
- Department of Dermatology, Toulouse University Hospital, 31400 Toulouse, France; GRPso (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie), France.
| |
Collapse
|
2
|
Fougerousse AC, Reguiai Z, Maccari F, Guillem P, Perrot JL. Hidradenitis suppurativa: Influence of hormonal factors on disease activity in women in France. Ann Dermatol Venereol 2023; 150:274-275. [PMID: 37652812 DOI: 10.1016/j.annder.2023.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 04/05/2023] [Accepted: 06/26/2023] [Indexed: 09/02/2023]
Affiliation(s)
- A-C Fougerousse
- Dermatology Department, Military Teaching Hospital Begin, Saint-Mandé, France.
| | - Z Reguiai
- Dermatology Department, Courlancy Polyclinic, Reims-Bezannes, France
| | - F Maccari
- Dermatology, Private practice, La Varenne Saint Hilaire, France
| | - P Guillem
- Visceral Surgery Department, Val d'Ouest Clinic, Ecully, France
| | - J-L Perrot
- Dermatology Department, University Hospital of Saint Etienne, Saint Etienne, France
| |
Collapse
|
3
|
Reguiai Z, Becherel PA, Fougerousse AC, Chaby G, Perrot JL, Begon E, Jacobzone-Lévêque C, Boulard C, Badaoui A, Poreaux C, David L, Quiles-Tsimaratos N, Lons-Danic D, Fite C, Liegeon AL, Patchinsky A, Parier J, Garcia C, Estève E, Mohty R, Mery-Bossard L, Maccari F. Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures. J Eur Acad Dermatol Venereol 2023; 37:e1307-e1309. [PMID: 37415328 DOI: 10.1111/jdv.19302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Accepted: 06/26/2023] [Indexed: 07/08/2023]
Affiliation(s)
- Z Reguiai
- Department of Dermatology, Polyclinique Courlancy, Reims-Bezannes, France
| | - P A Becherel
- Dermatology and Clinical Immunology Unit, Antony Hospital, Antony, France
| | - A C Fougerousse
- Department of Dermatology, Hôpital d'Instruction des Armées Begin, Saint Mandé, France
| | - G Chaby
- Department of Dermatology, CHU Amiens-Picardie, Amiens, France
| | - J L Perrot
- Department of Dermatology, CHU Saint Etienne, Saint Etienne, France
| | - E Begon
- Department of Dermatology, Centre Hospitalier René Dubos, Pontoise, France
| | | | - C Boulard
- Department of Dermatology, Centre Hospitalier Le Havre, Le Havre, France
| | | | - C Poreaux
- Centre de Dermatologie Stanislas, Clinique Pasteur, Nancy, France
| | - L David
- Department of Dermatology, Hopital Saint Joseph, Marseille, France
| | | | - D Lons-Danic
- Department of Dermatology, Hôpital Paris Saint Joseph, Paris, France
| | - C Fite
- Department of Dermatology, Hôpital Paris Saint Joseph, Paris, France
| | - A-L Liegeon
- Department of Dermatology, Centre Hospitalier Régional Metz-Thionville, Thionville, France
| | - A Patchinsky
- Department of Dermatology, Centre Hospitalier Régional Metz-Thionville, Thionville, France
| | - J Parier
- Centre de Santé Sabouraud, Hôpital Saint-Louis, Paris, France
- Cabinet Médical, Saint-Maur-des-Fossés, France
| | - C Garcia
- Department of Dermatology, Centre Hospitalier Emile Roux, Le Puy-en-Velay, France
| | - E Estève
- Department of Dermatology, Centre Hospitalier d'Orléans, Orléans, France
| | - R Mohty
- Cabinet Médical, Beauvais, France
| | - L Mery-Bossard
- Department of Dermatology, CHI Poissy Saint Germain, Saint-Germain-en-Laye, France
| | - F Maccari
- Department of Dermatology, Hôpital d'Instruction des Armées Begin, Saint Mandé, France
- Cabinet Médical, Saint-Maur-des-Fossés, France
| |
Collapse
|
4
|
Chikha SB, Bougatef H, Capitani F, Ben Amor I, Maccari F, Gargouri J, Sila A, Volpi N, Bougatef A. Composition and Anticoagulant Potential of Chondroitin Sulfate and Dermatan Sulfate from Inedible Parts of Garfish ( Belone belone). Foods 2023; 12:3887. [PMID: 37959006 PMCID: PMC10647378 DOI: 10.3390/foods12213887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Revised: 10/16/2023] [Accepted: 10/19/2023] [Indexed: 11/15/2023] Open
Abstract
Glycosaminoglycans (GAGs) play a crucial role due to their significant biomedical functions. Chondroitin sulfate (CS) and dermatan sulfate (DS), the main representative family of GAGs, were extracted and purified from garfish (Belone belone) by-products, i.e., skin (GSB), bones (GCB), and heads (GHB), and their composition and anticoagulant activity were investigated. CS/DS were purified by ion-exchange chromatography with yields of 8.1% for heads, 3.7% for skin, and 1.4% for bones. Cellulose acetate electrophoresis was also explored for analyzing the extracted CS/DS. Interestingly, GHB, GSB, and GCB possessed sulfate contents of 21 ± 2%, 20 ± 1%, and 20 ± 1.5%, respectively. Physico-chemical analysis showed that there were no significant differences (p > 0.05) between the variances for sulfate, uronic acid, and total sugars in the GAGs extracted from the different parts of fish. Disaccharide analysis by SAX-HPLC showed that the GSB and GCB were predominately composed of ΔDi-4S [ΔUA-GalNAc 6S] (74.78% and 69.22%, respectively) and ΔDi-2,4S [ΔUA2S-GalNAc 4S] (10.92% and 6.55%, respectively). However, the GHB consisted of 25.55% ΔDi-6S [ΔUA-GalNAc 6S] and 6.28% ΔDi-2,6S [ΔUA2S-GalNAc 4S]. Moreover, classical anticoagulation tests were also used to measure their anticoagulant properties in vitro, which included the activated partial thromboplastin time, prothrombin time, and thrombin time. The CS/DS isolated from garfish by-products exhibited potent anticoagulant effects. The purified CS/DS showed exceptional anticoagulant properties according to this research and can be considered as a new agent with anticoagulant properties.
Collapse
Affiliation(s)
- Sawssen Ben Chikha
- Laboratory for the Improvement of Plants and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia; (S.B.C.); (H.B.); (A.S.)
| | - Hajer Bougatef
- Laboratory for the Improvement of Plants and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia; (S.B.C.); (H.B.); (A.S.)
| | - Federica Capitani
- Clinical and Experimental Medicine Ph.D. Program, University of Modena and Reggio Emilia, 41121 Modena, Italy;
| | - Ikram Ben Amor
- Sfax Regional Blood Transfusion Center, El-Ain Road km 0.5, Sfax 3003, Tunisia;
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy; (F.M.); (N.V.)
| | - Jalel Gargouri
- Laboratory of Hematology, Medical Faculty of Sfax, University of Sfax, Magida Boulila Avenue, Sfax 3029, Tunisia;
| | - Assaad Sila
- Laboratory for the Improvement of Plants and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia; (S.B.C.); (H.B.); (A.S.)
- Department of Life Sciences, Faculty of Sciences of Gafsa, University of Gafsa, Gafsa 2100, Tunisia
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy; (F.M.); (N.V.)
| | - Ali Bougatef
- Laboratory for the Improvement of Plants and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia; (S.B.C.); (H.B.); (A.S.)
- High Institute of Biotechnology of Sfax, University of Sfax, Sfax 3038, Tunisia
| |
Collapse
|
5
|
Gatto F, Bratulic S, Jonasch E, Limeta A, Maccari F, Galeotti F, Volpi N, Lundstam S, Nielsen J, Stierner U. Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. JCO Precis Oncol 2023; 7:e2200361. [PMID: 36848607 DOI: 10.1200/po.22.00361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023] Open
Abstract
PURPOSE No liquid biomarkers are approved in metastatic renal cell carcinoma (mRCC) despite the need to predict and monitor response noninvasively to tailor treatment choices. Urine and plasma free glycosaminoglycan profiles (GAGomes) are promising metabolic biomarkers in mRCC. The objective of this study was to explore if GAGomes could predict and monitor response in mRCC. PATIENTS AND METHODS We enrolled a single-center prospective cohort of patients with mRCC elected for first-line therapy (ClinicalTrials.gov identifier: NCT02732665) plus three retrospective cohorts (ClinicalTrials.gov identifiers: NCT00715442 and NCT00126594) for external validation. Response was dichotomized as progressive disease (PD) versus non-PD every 8-12 weeks. GAGomes were measured at treatment start, after 6-8 weeks, and every third month in a blinded laboratory. We correlated GAGomes with response and developed scores to classify PD versus non-PD, which were used to predict response at treatment start or after 6-8 weeks. RESULTS Fifty patients with mRCC were prospectively included, and all received tyrosine kinase inhibitors (TKIs). PD correlated with alterations in 40% of GAGome features. We developed plasma, urine, and combined glycosaminoglycan progression scores that monitored PD at each response evaluation visit with the area under the receiving operating characteristic curve (AUC) of 0.93, 0.97, and 0.98, respectively. For internal validation, the scores predicted PD at treatment start with the AUC of 0.66, 0.68, and 0.74 and after 6-8 weeks with the AUC of 0.76, 0.66, and 0.75. For external validation, 70 patients with mRCC were retrospectively included and all received TKI-containing regimens. The plasma score predicted PD at treatment start with the AUC of 0.90 and at 6-8 weeks with the AUC of 0.89. The pooled sensitivity and specificity were 58% and 79% at treatment start. Limitations include the exploratory study design. CONCLUSION GAGomes changed in association with mRCC response to TKIs and may provide biologic insights into mRCC mechanisms of response.
Collapse
Affiliation(s)
- Francesco Gatto
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.,Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
| | - Sinisa Bratulic
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Eric Jonasch
- Division of Cancer Medicine, Department of Genitourinary Medical Oncology, MD Anderson Cancer Center of the University of Texas, Houston, TX
| | - Angelo Limeta
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Sven Lundstam
- Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.,Department of Oncology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.,BioInnovation Institute, Copenhagen, Denmark
| | - Ulrika Stierner
- Department of Oncology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| |
Collapse
|
6
|
Gatto F, Dabestani S, Bratulic S, Limeta A, Maccari F, Galeotti F, Volpi N, Stierner U, Nielsen J, Lundstam S. Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study. EUR UROL SUPPL 2022; 42:30-39. [PMID: 35911082 PMCID: PMC9334826 DOI: 10.1016/j.euros.2022.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/09/2022] [Indexed: 11/17/2022] Open
Affiliation(s)
- Francesco Gatto
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
- Corresponding authors. Department of Oncology-Pathology, Karolinska Institute, 171 64 Stockholm, Sweden (F. Gatto). Department of Urology, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden (S. Lundstam).
| | - Saeed Dabestani
- Department of Translational Medicine, Division of Urological Cancers, Lund University, Kristianstad Central Hospital, Region Skane, Lund, Sweden
- Department of Urology, Kristianstad Central Hospital, Region Skane, Kristianstad, Sweden
| | - Sinisa Bratulic
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Angelo Limeta
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Ulrika Stierner
- Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
- BioInnovation Institute, Copenhagen N, Denmark
| | - Sven Lundstam
- Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
- Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
- Corresponding authors. Department of Oncology-Pathology, Karolinska Institute, 171 64 Stockholm, Sweden (F. Gatto). Department of Urology, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden (S. Lundstam).
| |
Collapse
|
7
|
Francese R, Donalisio M, Rittà M, Capitani F, Mantovani V, Maccari F, Tonetto P, Moro GE, Bertino E, Volpi N, Lembo D. Human milk glycosaminoglycans inhibit cytomegalovirus and respiratory syncytial virus infectivity by impairing cell binding. Pediatr Res 2022:10.1038/s41390-022-02091-y. [PMID: 35513714 DOI: 10.1038/s41390-022-02091-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Revised: 04/08/2022] [Accepted: 04/13/2022] [Indexed: 11/09/2022]
Abstract
BACKGROUND The antiviral role of glycosaminoglycans in human milk (HM-GAGs) has been poorly investigated. They are highly sulfated polysaccharides, which were proposed to act as decoy receptors according to their structure. The aim of this study is to evaluate the antiviral potential and the mechanism of action of total and individual HM-GAGs against three pediatric clinically relevant viruses: respiratory syncytial virus (RSV), cytomegalovirus (HCMV), and rotavirus. METHODS HM-GAGs were isolated from HM and a library of individual GAGs, structurally related to HM-GAGs, was prepared. The antiviral activity of HM-GAGs and the impact of thermal treatment were investigated in vitro by specific antiviral assays. RESULTS We demonstrated that HM-GAGs are endowed with anti-HCMV and anti-RSV activity and that they act by altering virus attachment to cell. We clarified the contribution of individual HM-GAGs, showing a specific structure-related activity. We did not observe any alteration of HM-GAG antiviral activity after thermal treatment. CONCLUSIONS We showed that HM-GAGs contribute to the overall antiviral activity of HM, likely exerting a synergic action with other HM antiviral agents. HM-GAGs can now be added to the list of endogenous factors that may reduce breast-milk-acquired HCMV symptomatic infections and protecting infants from respiratory tract infections by RSV. IMPACT HM-GAGs have been poorly investigated for their antiviral action so far. We demonstrated that HM-GAGs are endowed with significant anti-HCMV and anti-RSV activity and that they are able to alter virus binding to the cell. The contribution of individual HM-GAGs is mainly exerted by the FMHep and is not based on a simple charge interaction between the virus and sulfate groups but involves a specific GAG structural configuration. Our results contribute to identifying the multiple factors synergically acting in mediating HM antiviral properties and to clarifying their specific mechanism of action.
Collapse
Affiliation(s)
- Rachele Francese
- Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, Orbassano (TO), Italy
| | - Manuela Donalisio
- Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, Orbassano (TO), Italy
| | - Massimo Rittà
- Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, Orbassano (TO), Italy
| | - Federica Capitani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
| | - Veronica Mantovani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Paola Tonetto
- Department of Public Health and Pediatrics, Neonatal Intensive Care Unit, University of Turin, Turin, Italy
| | - Guido E Moro
- Italian Association of Human Milk Banks (AIBLUD), Milan, Italy
| | - Enrico Bertino
- Department of Public Health and Pediatrics, Neonatal Intensive Care Unit, University of Turin, Turin, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
| | - David Lembo
- Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, Orbassano (TO), Italy.
| |
Collapse
|
8
|
Aubert H, Mahé E, Fougerousse AC, Maccari F, Beneton N. Dose spacing and reduction strategies in biotherapies for stable, clear or almost clear psoriasis: A survey of practices in France. Ann Dermatol Venereol 2021; 149:68-70. [PMID: 34887084 DOI: 10.1016/j.annder.2021.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Revised: 05/12/2021] [Accepted: 07/01/2021] [Indexed: 11/26/2022]
Affiliation(s)
- H Aubert
- Department of Dermatology, Centre Hospitalier Universitaire, 1, avenue Alexis-Ricordeau, 44000 Nantes, France.
| | - E Mahé
- Department of Dermatology, Hôpital Victor Dupouy, 69, rue du Lieutenant-Colonel Prud'hon, 95100 Argenteuil, France
| | - A-C Fougerousse
- Department of Dermatology, 69, Avenue de Paris, 94160 Saint-Mandé, France
| | | | - N Beneton
- Department of Dermatology, Centre Hospitalier, 194, Avenue Rubillard, 72037 Le Mans, France
| | | |
Collapse
|
9
|
Gatto F, Bratulic S, Jonasch E, Limeta A, Maccari F, Galeotti F, Volpi N, Lundstam S, Nielsen J, Stierner U. Plasma and urine free glycosaminoglycans as monitoring and predictive biomarkers in metastatic renal cell carcinoma: A prospective observational study. J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.e16540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e16540 Background: No liquid biomarkers are approved in renal cell carcinoma (RCC). In metastatic RCC (mRCC), there is a need to predict and monitor response noninvasively to guide the choice of treatment. Urine and plasma glycosaminoglycan (GAGs) profiles – or GAGomes - are promising biomarkers reflective of RCC metabolism. Here, we explored if GAGomes could predict and monitor response noninvasively. Methods: A single-center prospective consecutive series of mRCC patients elected for first-line therapy was enrolled between June 2016 - April 2019 at Sahlgrenska University Hospital, Gothenburg, Sweden. Response was assessed by the investigator as progressive disease (PD) versus non-PD. Plasma and urine GAGomes were measured at treatment start, after 6 weeks, and every 3rd month in a blinded central laboratory. We conducted Bayesian estimation to correlate GAGomes to response and to design GAG scores to classify PD. So-trained GAG scores were validated to predict PD vs. non-PD at treatment start or after 6 weeks. Results: Fifty patients with treatment-naïve mRCC were enrolled (median age: 68.5 years, 33% female). All received tyrosine-kinase inhibitors (37 sunitinib, 4 pazopanib, 9 cabozantinib). The median follow-up time was 3.5 months, totaling 65 response evaluation visits - 23 PD and 42 non-PD. PD was compatible with alterations in 40% of the detectable GAGome features. These were used to design a plasma, urine, and combined GAG progression score to classify PD vs. non-PD at response evaluation. The area-under-the-curve (AUC) was 0.91 in plasma, 0.98 in urine, and 0.99 when combined. In validation, the AUC to predict PD at treatment start was 0.64 in plasma, 0.63 in urine, and 0.71 when combined (N = 50); and, after 6 weeks, 0.75 in plasma, 0.66 in urine, and 0.80 when combined (N = 47). The combined GAG progression score had 62% sensitivity and 86% specificity to PD at treatment start and 67% and 87% after 6 weeks. Conclusions: GAGomes correlated with treatment response in mRCC. GAG scores were validated for the early prediction of response. Their clinical utility remains to be ascertained. Clinical trial information: NCT02732665.
Collapse
Affiliation(s)
| | - Sinisa Bratulic
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Eric Jonasch
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Angelo Limeta
- Chalmers University of Technology, Gothenburg, Sweden
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Sven Lundstam
- Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | - Ulrika Stierner
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden
| |
Collapse
|
10
|
Gatto F, Bratulic S, Cavarretta ITR, Alfano M, Maccari F, Galeotti F, Volpi N, Edqvist PH, Levin M, Nyman J, Bergman B, Salonia A, Lundstam S, Stierner U, Kjölhede H, Nielsen J. Detection of any-stage cancer using plasma and urine glycosaminoglycans. J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.3034] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3034 Background: Non-invasive liquid biopsies promise to enable early cancer detection and improve patient outcomes. However, virtually all liquid biopsies rely on genomic biomarkers, with limited sensitivity to early-stage tumors and poor detection of cancers shedding little cell-free DNA, like genitourinary or brain tumors. Here, we explored the use of plasma and urine glycosaminoglycan (GAGs) profiles, or GAGomes, as biomarkers reflective of tumor metabolism to serve as an alternative pan-cancer liquid biopsy. Methods: In this case-control study, we enrolled retrospective and prospective cohorts from Sweden and Italy. Included cases were treatment-naïve early-stage/low-grade cancers or metastatic/high-grade cancers across 14 histological types. Included controls were healthy 22-78 y/o adults with no history of cancer. We measured GAGomes – encompassing 17 chondroitin sulfate (CS), heparan sulfate (HS), and hyaluronate (HA) disaccharides - using a standardized UHPLC-MS/MS-based kit in a central blind laboratory. We tested the top GAGome features different in cancer using Bayesian estimation. These were used to design one plasma and one urine GAG score for the binary classification of cancer vs. control in a discovery set. We computed the area-under-the-curve (AUC), and sensitivity at 98% specificity of each GAG score in the validation set. A subset analysis was performed in early-stage/low-grade cancers only. In the subset of cases with survival records, we used multivariable Cox regression to estimate the hazard ratio (HR) for overall survival (OS) on each GAG score adjusted for cancer type, age, and gender. Results: GAGomes were measured in 753 plasma samples (460 cancers across 14 types, median age = 66 y/o, 51% female vs. 293 healthy adults, median age = 58 y/o, 57% female) and 559 urine samples (219 cancers across 5 types, median age = 69 y/o, 23% female vs. 340 healthy adults, median age = 56 y/o, 60% female). In the discovery set, the urine GAG score had an AUC = 0.80 (95% CI: 0.74-0.85, 124 cancers across 5 types vs. 184 controls) while the plasma GAG score had an AUC = 0.82 (95% CI: 0.78-0.86, 153 cancers across 14 types vs. 282 controls). In the validation set, the urine GAG score had an AUC = 0.78 (95% CI: 0.71-0.84, 95 cancers across 5 types vs. 156 controls) with 35% sensitivity at 98% specificity. The plasma GAG score had an AUC = 0.84 (95% CI: 0.79-0.88, 178 cancers across 14 types vs. 140 controls) with 41% sensitivity at 98% specificity. In the subset of early-stage/low-grade cancers, the AUC was 0.78 and 0.72 in plasma and urine, respectively. The plasma and urine GAG scores were independent predictors of OS regardless of cancer type (HR = 1.39, p = 0.005 in plasma [ N = 283, 11 types, 67 deaths, median follow-up 17 months] and HR = 1.53, p = 0.016 in urine [ N = 161, 4 types, 32 deaths, median follow-up 15 months]). Conclusions: GAGomes were sensitive non-invasive metabolic biomarkers for any-stage cancer, including genitourinary and brain tumors.
Collapse
Affiliation(s)
| | - Sinisa Bratulic
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | | | - Massimo Alfano
- IRCCS Ospedale San Raffaele, Urological Research Institute, Milan, Italy
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | | | - Max Levin
- The Wallenberg Laboratory, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Jan Nyman
- Department of Oncology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Bengt Bergman
- Department of Respiratory Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Andrea Salonia
- IRCCS Ospedale San Raffaele, Urological Research Institute, Milan, Italy
| | - Sven Lundstam
- Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Ulrika Stierner
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Henrik Kjölhede
- Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
| | | |
Collapse
|
11
|
Tamburro D, Bratulic S, Abou Shameh S, Soni NK, Bacconi A, Maccari F, Galeotti F, Mattsson K, Volpi N, Nielsen J, Gatto F. Analytical performance of a standardized kit for mass spectrometry-based measurements of human glycosaminoglycans. J Chromatogr B Analyt Technol Biomed Life Sci 2021; 1177:122761. [PMID: 34052753 DOI: 10.1016/j.jchromb.2021.122761] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Revised: 04/27/2021] [Accepted: 05/09/2021] [Indexed: 12/17/2022]
Abstract
Glycosaminoglycans (GAGs) are long linear sulfated polysaccharides implicated in processes linked to disease development such as mucopolysaccharidosis, respiratory failure, cancer, and viral infections, thereby serving as potential biomarkers. A successful clinical translation of GAGs as biomarkers depends on the availability of standardized GAG measurements. However, owing to the analytical complexity associated with the quantification of GAG concentration and structural composition, a standardized method to simultaneously measure multiple GAGs is missing. In this study, we sought to characterize the analytical performance of a ultra-high-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry (UHPLC-MS/MS)-based kit for the quantification of 17 free GAG disaccharides. The kit showed acceptable linearity, selectivity and specificity, accuracy and precision, and analyte stability in the absolute quantification of 15 disaccharides. In native human samples, here using urine as a reference matrix, the analytical performance of the kit was acceptable for the quantification of CS disaccharides. Intra- and inter-laboratory tests performed in an external laboratory demonstrated robust reproducibility of GAG measurements showing that the kit was acceptably standardized. In conclusion, these results indicated that the UHPLC-MS/MS kit was standardized for the simultaneous measurement of free GAG disaccharides allowing for comparability of measurements and enabling translational research.
Collapse
Affiliation(s)
| | - Sinisa Bratulic
- Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Göteborg, Sweden
| | | | - Nikul K Soni
- Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Göteborg, Sweden
| | | | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
| | | | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Göteborg, Sweden; BioInnovation Institute, DK 2200 Copenhagen, Denmark
| | - Francesco Gatto
- Elypta AB, 171 65 Solna, Sweden; Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Göteborg, Sweden.
| |
Collapse
|
12
|
Galeotti F, Capitani F, Maccari F, Mantovani V, Volpi N. Capillary Electrophoresis Separation of Artepillin C: Determination in Brazilian Green Propolis. J Chromatogr Sci 2021; 59:994-1003. [PMID: 33604611 DOI: 10.1093/chromsci/bmab015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Indexed: 11/12/2022]
Abstract
Propolis is important in complementary and alternative medicine having well-known therapeutic applications. Artepillin C, a main component of Brazilian (green) propolis, has attracted great attention for its anticancer action. Consequently, the synthesis of artepillin C has been reported but, due to the limited yield and elevated costs, this biomolecule is largely produced from Brazilian propolis. We report the capillary electrophoresis (CE) separation of artepillin C in Brazilian propolis also comparing the results with those of HPLC-UV-MS. Optimal separation was obtained with a simple buffer constituted of sodium tetraborate 30 mM pH 9.2 and detection at 210 nm. Artepillin C and the polyphenols of propolis were fully separated with a voltage gradient of 30 to 8 kV and a current of 300 μA for a total run of 50 min. The sensitivity of CE-UV was 22 times greater than HPLC-UV and 100 times more than HPLC-MS with also a stronger reduction in the run time and a greater robustness and reproducibility. The development of CE as an effective and reliable method for the analysis of artepillin C is desired as the standardized quality controls are essential before propolis or its biomolecules can be adopted routinely in nutraceuticals, food ingredients and therapeutic applications.
Collapse
Affiliation(s)
- Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy
| | - Federica Capitani
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy
| | - Veronica Mantovani
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy.,Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/D, 41125 Modena, Italy
| |
Collapse
|
13
|
Volpi N, Galeotti F, Maccari F, Capitani F, Mantovani V. Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process. J Pharm Biomed Anal 2020; 195:113826. [PMID: 33358299 DOI: 10.1016/j.jpba.2020.113826] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Revised: 12/02/2020] [Accepted: 12/03/2020] [Indexed: 10/22/2022]
Abstract
We report results on the structure, physicochemical characteristics and purity of chondroitin sulfate (CS) samples derived from three largely available and common biological sources such as bovine and porcine trachea and chicken keel bones with the aim to define their structural signatures. Many lots of CS produced by a manufacturer at industrial scale were characterized with a view to assess the reproducibility of the process as not controlled extractive procedures may produce final products with variable structure and biological contaminants as well as not constant clinical efficacy and safety. By using standardized source animal tissues and manufacturing procedure, highly pure CS (∼92 %) products with constant structure and characteristics were obtained. Bovine CS showed a lower molecular weight (MWw of ∼21,500 Da) than porcine (MWw of ∼26,000 Da) and chicken (MWw of ∼35,900 Da) products with a CV% of ∼2.0-7.5 and a polydispersity variability of 0.7-2.7 %. The ratio between the sulfate groups main located in position 4 and 6 of N-acetyl-galactosamine (4/6 ratio) was ∼1.70 for bovine CS versus a value of 3.60 for porcine and ∼2.70 for chicken samples with a overall charge density of 0.92-0.93 and a CV% of 2.1-2.5. The final products also showed the presence of a very low and constant content of other co-purified bio(macro)molecules (hyaluronic acid, keratan sulfate, dermatan sulfate, heparan sulfate, nucleic acids and proteins), calcium and sodium, and the absence of versican. Finally, a high reproducibility of molecular weight values, disaccharide composition, specific optical rotation and particle dimension was observed. The observed parameters are structural signatures useful to specifically identify the origin of CS and obtained by a standardized and highly reproducible manufacturing process. The compositional profile determined from this study provides a measure of the norm and range of variation in CS samples of terrestrial origin produced under standardized production protocol to which future pharmaceutical/nutraceutical final products can be compared. Moreover, the physicochemical properties including molecular weight, disaccharide composition, presence of natural contaminants and particle dimension were characterized to provide the basis of CS of high quality for application as pharmaceutical/nutraceutical active agents.
Collapse
Affiliation(s)
- Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Federica Capitani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Veronica Mantovani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
14
|
Maccari F, Fougerousse A, Reguiai Z, Taieb C. Contraception, sexualité et grossesse chez les femmes atteintes de psoriasis : expérience vécue de 235 femmes. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z. Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19. J Eur Acad Dermatol Venereol 2020; 34:e676-e679. [PMID: 32564417 PMCID: PMC7323155 DOI: 10.1111/jdv.16761] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Revised: 05/18/2020] [Accepted: 05/22/2020] [Indexed: 12/01/2022]
Affiliation(s)
- A-C Fougerousse
- Dermatology Department, Military Teaching Hospital Bégin, Saint Mandé, France
| | - M Perrussel
- Private Practice Auray, Dermatology Department, University Hospital Rennes, Rennes, France
| | - P-A Bécherel
- Dermatology Department, Private Hospital, Antony, France
| | - E Begon
- Dermatology Department, Centre Hospitalier Pontoise, Pontoise, France
| | - V Pallure
- Dermatology Department, Perpignan Hospital, Perpignan, France
| | - I Zaraa
- Dermatology Department, Saint-Joseph Hospital, Paris, France
| | - G Chaby
- Dermatology Department, University Hospital, Amiens, France
| | - J Parier
- Private Practice, La Varenne Saint Hilaire, France.,Dermatology Department, Saint Louis Hospital, Paris, France
| | - M Kemula
- Private Practice, Paris, France.,Dermatology Department, Tarnier Hospital, Paris, France
| | - L Mery-Bossard
- Dermatology Department, Centre Hospitalier Intercommunal Poissy-Saint Germain en Laye, Poissy, France
| | - C Poreaux
- Private Practice, Nancy, Pasteur Clinic, Essey-les-Nancy, France
| | - C Taieb
- Emma Clinic, Fontenay sous Bois, France
| | - F Maccari
- Dermatology Department, Military Teaching Hospital Bégin, Saint Mandé, France.,Private Practice, La Varenne Saint Hilaire, France
| | - Z Reguiai
- Dermatology Department, Courlancy Polyclinic, Reims-Bezannes, France
| | | |
Collapse
|
16
|
Reguiaï Z, Fougerousse A, Maccari F, Bécherel P. Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases). J Eur Acad Dermatol Venereol 2020; 34:e750-e751. [DOI: 10.1111/jdv.16605] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Z. Reguiaï
- Dermatology Department Polyclinique Courlancy Reims France
- GEM Resoverneuil
| | - A.C. Fougerousse
- GEM Resoverneuil
- Dermatology Department Military Hospital Begin Saint‐Mandé France
| | - F. Maccari
- GEM Resoverneuil
- Dermatology Department Military Hospital Begin Saint‐Mandé France
| | - P.A. Bécherel
- GEM Resoverneuil
- Dermatology and Clinical Immunology Unit Antony Hospital Antony France
| |
Collapse
|
17
|
Mahé E, Corgibet F, Maccari F, Hadj-Rabia S, Phan C, Ruer-Mulard M, Boralévi F, Barbarot S, Bursztejn AC, Lahfa M, Severino-Freire M, Aubin F, Barthélémy H, Amy de la Bretêque M, Beauchet A. Prescriptions hors AMM (autorisation de mise sur le marché) dans le psoriasis de l’enfant. Ann Dermatol Venereol 2020; 147:429-438. [DOI: 10.1016/j.annder.2020.01.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2019] [Revised: 01/03/2020] [Accepted: 01/27/2020] [Indexed: 01/13/2023]
|
18
|
Fougerousse A, Ghislain P, Reguiai Z, Maccari F, Parier J, Bouilly Auvray D, Chaby G, Pallure V, Schmutz J, Clément C, Jacobzone C, Begon E, Esteve E. Effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis under real‐life conditions: a retrospective multicenter study. J Eur Acad Dermatol Venereol 2020; 34:e644-e646. [DOI: 10.1111/jdv.16511] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Accepted: 04/10/2020] [Indexed: 12/28/2022]
Affiliation(s)
- A.‐C. Fougerousse
- Dermatology Department Military Teaching Hospital Bégin St Mandé France
| | - P.‐D. Ghislain
- Dermatology Department Private Practice St‐Luc University Hospital BruxellesMons Belgium
| | - Z. Reguiai
- Dermatology Department Courlancy Polyclinic Reims France
| | | | | | | | - G. Chaby
- Dermatology Department University Hospital Amiens France
| | - V. Pallure
- Dermatology Department Perpignan Hospital Perpignan France
| | - J.‐L. Schmutz
- Dermatology Department University Hospital Brabois Vandoeuvre les Nancy France
| | - C. Clément
- Dermatology Department University Hospital of Côte de Nacre Caen France
| | - C. Jacobzone
- Dermatology Department University Hospital of Lorient Lorient France
| | - E. Begon
- Dermatology Department Pontoise Hospital Pontoise France
| | - E. Esteve
- Dermatology Department Regional Hospital Orléans France
| | | |
Collapse
|
19
|
Amy de la Bretèque M, Beauchet A, Maccari F, Ruer-Mulard M, Bastien M, Chaby G, Le Guyadec T, Estève E, Parier J, Dauendorffer JN, Barthelemy H, Géner G, Wagner L, Pfister P, Bégon E, Mery-Bossard L, Schmutz JL, Mahé E. Les patients psoriasiques vus en cabinet libéral et à l’hôpital sont-ils différents ? Ann Dermatol Venereol 2020; 147:310-312. [DOI: 10.1016/j.annder.2019.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Accepted: 12/12/2019] [Indexed: 10/25/2022]
|
20
|
Grodner C, Beauchet A, Fougerousse A, Quiles‐Tsimaratos N, Perrot J, Barthelemy H, Parier J, Maccari F, Beneton N, Bouilly‐Auvray D, Ruer‐Mulard M, Boulard C, Jacobzone C, Thomas‐Beaulieu D, Pourchot D, Méry‐Bossard L, Chaby G, Girard C, Duval‐Modeste A, Vermersch‐Langlin A, Delaunay J, Marc S, Kemula M, Steff M, Bilan P, Liégeon A, Aubert H, Solyga B, Kluger N, Mahé E. Tattoo complications in treated and non‐treated psoriatic patients. J Eur Acad Dermatol Venereol 2020; 34:888-896. [DOI: 10.1111/jdv.15975] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Accepted: 09/04/2019] [Indexed: 11/27/2022]
Affiliation(s)
- C. Grodner
- Dermatology Department Hôpital Victor Dupouy Argenteuil France
| | - A. Beauchet
- Public Health Department Hôpital Ambroise Paré Boulogne‐Billancourt France
| | - A.‐C. Fougerousse
- Dermatology Department Hôpital d'Instruction des Armées Bégin Saint Mandé France
| | | | - J.‐L. Perrot
- Dermatology Department CHU Saint‐Etienne Saint‐Etienne France
| | - H. Barthelemy
- Dermatology Department Centre Hospitalier d'Auxerre Auxerre France
| | - J. Parier
- Private Office La Varenne St Hilaire France
| | - F. Maccari
- Private Office La Varenne St Hilaire France
| | - N. Beneton
- Dermatology Department Centre Hospitalier du Mans Le Mans France
| | - D. Bouilly‐Auvray
- Dermatology Department Centre Hospitalier Universitaire de Dijon Dijon France
| | | | - C. Boulard
- Dermatology Department Hôpital Jacques Monod Le Havre Cedex France
| | - C. Jacobzone
- Dermatology Department Centre Hospitalier de Lorient Lorient France
| | - D. Thomas‐Beaulieu
- Dermatology Department Centre Hospitalier Intercommunal de Poissy/Saint‐Germain‐en‐Laye Saint‐Germain‐en‐Laye France
| | - D. Pourchot
- Dermatology Department Centre Hospitalier Intercommunal de Poissy/Saint‐Germain‐en‐Laye Saint‐Germain‐en‐Laye France
| | - L. Méry‐Bossard
- Dermatology Department Centre Hospitalier Intercommunal de Poissy/Saint‐Germain‐en‐Laye Saint‐Germain‐en‐Laye France
| | - G. Chaby
- Dermatology Department Hôpital Sud Amiens France
| | - C. Girard
- Dermatology Department Centre Hospitalier Universitaire de Montpellier Montpellier France
| | - A.‐B. Duval‐Modeste
- Dermatology Department Centre Hospitalier Universitaire Charles‐Nicolle Rouen France
| | | | | | - S. Marc
- Dermatology Department Hôpital François Quesnay Mantes La Jolie France
| | | | - M. Steff
- Dermatology Department Hôpital Intercommunal Robert‐Ballanger Aulnay‐sous‐Bois France
| | - P. Bilan
- Dermatology Department Hôpital Intercommunal Robert‐Ballanger Aulnay‐sous‐Bois France
| | - A.‐L. Liégeon
- Dermatology Department Hôpital de Valence Valence France
| | - H. Aubert
- Dermatology Department Centre Hospitalier Universitaire de Nantes Nantes France
| | - B. Solyga
- Private Office Fontenay‐sous‐Bois France
| | - N. Kluger
- Dermatology Department, Allergology, and Venereology University of Helsinki and Helsinki University Central Hospital Helsinki Finland
- Dermatology Department Tattoo Consultation Centre Hospitalier Universitaire Bichat‐Claude Bernard Assistance Publique‐Hôpitaux de Paris Paris France
| | - E. Mahé
- Dermatology Department Hôpital Victor Dupouy Argenteuil France
| | | |
Collapse
|
21
|
Halioua B, Maccari F, Fougerousse AC, Parier J, Reguiai Z, Taieb C, Esteve E. Impact of patient psoriasis on partner quality of life, sexuality and empathy feelings: a study in 183 couples. J Eur Acad Dermatol Venereol 2020; 34:2044-2050. [PMID: 32173921 DOI: 10.1111/jdv.16270] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2019] [Accepted: 01/13/2020] [Indexed: 12/30/2022]
Abstract
BACKGROUND The impact of psoriasis on quality of life (QoL), sexuality and empathy requires better understanding in patient-partner relationships. OBJECTIVES To evaluate the influence of psoriasis on partner QoL, presence of sexual dysfunction (SDy) in couples and empathy in partners of psoriasis patients. METHODS A total of 183 adult psoriasis patients and their partners participated in this observational, cross-sectional and non-comparative study. Severity of psoriasis was measured using the Psoriasis Area and Severity Index. Patient QoL was assessed using the Dermatology Life Quality Index and the Short Form-12 (SF12). The impact of psoriasis on partner QoL was measured with the Family Pso and the SF12. Presence of SDy and empathy in partners were assessed using the Family Pso. RESULTS Overall, 49.7% of the patients had moderate-to-severe psoriasis. Patient psoriasis severity and patient QoL were correlated with partner psychological distress. The largest QoL impairment was observed in female patients with moderate-to-severe psoriasis. The stronger QoL alteration observed in female psoriasis patients, compared to their partners, was not observed in male psoriasis patients vs. their partners. There was no relationship between partner QoL and patient age and duration of psoriasis. Most patients, but less than half of the partners, reported SDy with age being a being a significantly more important impacting factor than disease severity. Both psoriasis clinical severity and/or a significant impact on QoL were associated factors for SDy in male partners of psoriasis women, but not in female partners of psoriatic men. Reporting empathy was higher among young male partners of psoriasis patients. In both male and female partners, patient psoriasis clinical severity was not associated with empathy. CONCLUSIONS Psoriasis impact on patient-partner QoL, sexuality and empathy should be considered more thoroughly by dermatologists when formulating treatment plans and making treatment decisions.
Collapse
Affiliation(s)
- B Halioua
- GEM Resopso, Dermatology Center, Paris, France
| | - F Maccari
- Service de Dermatologie, Hopital d'Instruction des Armees Begin, Saint-Maur-des-Fossés, France
| | | | - J Parier
- Private Practice, Saint-Maur-des-Fossés, France
| | | | - C Taieb
- Necker Enfants Malades Hospital, Paris, France
| | | |
Collapse
|
22
|
Jacobzone C, Reguiai Z, Fougerousse A, Mahé E, Maccari F, Badaoui A, Perrot JL, Esteve E, Thomas Beaulieu D, Begon E, Delaunay J, Pillette Delarue M, Jachiet M, Jouan N, Pallure V, Loget J, Bourrel M, Bénéton N, Steff M, Bilan P, Huet F, Parier J, Alice de Salins C, Osdoit S, Gabison G, Perrussel M, Lepelley-Dupont C, Sultan N, Taieb C, Barbarot S. Répartition des formes phénotypiques de la dermatite atopique chez l’adulte: premiers résultats de l’étude DAPHNE. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
23
|
Mahé E, Corgibet F, Phan C, Maccari F, Hadj-Rabia S, Ruer-Mulard M, Boralévi F, Barbarot S, Bursztejn AC, Lahfa M, Severino-Freire M, Aubin F, Barthelemy H, Amy de la Breteque M, Sialiti S, Beauchet A. Prescriptions hors AMM (autorisation de mise sur le marché) dans le psoriasis de l’enfant. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
24
|
Reguiai Z, Fougerousse A, Maccari F, Bécherel PA. Interet du sécukinumab pour le traitement de la maladie de Verneuil. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
25
|
Fougerousse AC, Reguiai Z, Boulard C, Begon E, Bénéton N, Chaby G, Delaunay J, Barthelemy H, Parier J, Mery-Bossard L, Maccari F, Bastien M, Lons Danic D, Perrot JL, Jacobzone C, Sultan N, Cottencin AC, Samimi M, Monfort JB, Trovato E, Mahe E. Switchs entre anti-IL17 chez 100 patients atteints de psoriasis: étude rétrospective multicentrique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Grodner C, Beauchet A, Fougerousse AC, Quiles-Tsimaratos N, Perrot JL, Barthelemy H, Parier J, Maccari F, Bénéton N, Bouilly-Auvray D, Ruer-Mulard M, Boulard C, Jacobzone C, Thomas-Beaulieu D, Méry-Bossard L, Pourchot D, Chaby G, Girard C, Duval-Modeste AB, Vermersch-Langlin A, Delaunay J, Marc S, Kemula M, Sigal ML, Amy de la Breteque M, Steff M, Bilan P, Liégeon AL, Aubert H, Solyga B, Kluger N, Mahé E. Complications des tatouages chez les patients psoriasiques avec ou sans traitements. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Fougerousse A, Maccari F, Beauchet A, Parier J, Boulard C, Becherel P, Quiles‐Tsimaratos N, Le Guyadec T, Thomas‐Beaulieu D, Halioua B, Begon E, Bastien M, Perrot J, Pallure V, Bilan P, Steff M, Pfister P, Vermersch‐Langlin A, Boyé T, Mery‐Bossard L, Maillard H, Kemula M, Girard C, Poiraud C, Monfort J, Kupfer‐Bessaguet I, Perrussel M, Lons‐Danic D, Sultan N, Lorier E, Zeitoun M, Wagner L, Gabison G, Mahé E. Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting. J Eur Acad Dermatol Venereol 2019; 33:e476-e478. [DOI: 10.1111/jdv.15804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- A.‐C. Fougerousse
- Dermatology Department Hôpital d'Instruction des Armées Bégin Saint Mandé France
| | - F. Maccari
- Private Office La Varenne Saint Hilaire France
| | - A. Beauchet
- Department of Public Health Centre Hospitalier Universitaire Ambroise Paré APHP & UVSQ Université Paris‐Saclay Boulogne‐Billancourt France
| | - J. Parier
- Private Office La Varenne Saint Hilaire France
| | - C. Boulard
- Dermatology Department Hôpital du Havre Montivilliers France
| | - P.‐A. Becherel
- Dermatology Department Hôpital Privé d'Antony Antony France
| | | | - T. Le Guyadec
- Dermatology Department Hôpital d'Instruction des Armées Percy Clamart France
| | - D. Thomas‐Beaulieu
- Dermatology Department Centre Hospitalier Intercommunal Poissy‐Saint Germain en Laye Poissy France
| | | | - E. Begon
- Dermatology Department Hôpital René Dubos Pontoise France
| | | | - J.‐L. Perrot
- Dermatology Department Centre Hospitalier Universitaire Saint Etienne France
| | - V. Pallure
- Dermatology Department Centre Hospitalier Perpignan France
| | - P. Bilan
- Dermatology Department Centre Hospitalier Robert Ballanger Aulnay‐sous‐Bois France
| | - M. Steff
- Dermatology Department Centre Hospitalier Robert Ballanger Aulnay‐sous‐Bois France
| | | | | | - T. Boyé
- Dermatology Department Hôpital d'Instruction des Armées Sainte Anne Toulon France
| | - L. Mery‐Bossard
- Dermatology Department Centre Hospitalier François Quesnay Mantes la Jolie France
| | - H. Maillard
- Dermatology Department Centre Hospitalier Le Mans France
| | | | - C. Girard
- Dermatology Department Centre Hospitalier Universitaire Sainte Eloi Montpellier France
| | - C. Poiraud
- Dermatology Department Centre Hospitalier La Roche sur Yon France
| | - J.‐B. Monfort
- Dermatology Department Centre Hospitalier Universitaire Tenon Paris France
| | | | | | - D. Lons‐Danic
- Dermatology Department Hôpital Saint Joseph Paris France
| | - N. Sultan
- Dermatology Department Centre Hospitalier Gabriel Martin Saint‐Paul France
| | | | | | | | | | - E. Mahé
- Dermatology Department Hôpital Victor Dupouy Argenteuil France
| | | |
Collapse
|
28
|
Aubert H, Mahé E, Fougerosse AC, Maccari F, Bénéton N. Stratégie d’espacement et de diminution des doses de traitement par biothérapie dans le psoriasis cutané en rémission ou avec une faible activité : enquête de pratique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
29
|
Fougerousse AC, Reguiai Z, Maccari F, Parier J, Schmutz JL, Begon E, Chaby G, Bouilly-Auvray D, Pallure V, Beneton N, Monfort JB, Boulard C, Delaunay J, Clément Lepley C, Bastien M, Mery Bossard L, Perrot JL, Jacobzone C, Vermersch A, Esteve E. Profil des patients à l’initiation du guselkumab : étude rétrospective multicentrique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Pricci F, Villa M, Maccari F, Agazio E, Rotondi D, Panei P, Roazzi P. The Italian Registry of GH Treatment: electronic Clinical Report Form (e-CRF) and web-based platform for the national database of GH prescriptions. J Endocrinol Invest 2019; 42:769-777. [PMID: 30443857 PMCID: PMC6581935 DOI: 10.1007/s40618-018-0980-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2018] [Accepted: 11/08/2018] [Indexed: 11/27/2022]
Abstract
BACKGROUND In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the "Note #39" included in the "Notes for the use of drugs" by the Italian Medicines Agency (AIFA), which are published in the Official Gazette, thus having the force of law. The "Note #39" establishes the diagnosis for which the reimbursement is granted and confirms the assignment of the national health surveillance on the use of GH therapy to the Italian National Institute of Health, requesting its computerization. AIM The aim of this work was to realize a dedicated electronic Clinical Report Form based on the mandatory data requested by the Note #39 and allowing the online reporting of the rGH prescriptions by the regional accredited centers. RESULTS AND CONCLUSIONS This interface is at the base of the national database of the Italian Registry of GH Treatment, which allows obtaining and managing correct and complete data to provide public health surveillance on GH therapy, both at national and local levels, necessary for policymakers decisions. In addition, this national database could be a useful instrument for improving knowledge about aspects of this treatment still under discussion.
Collapse
Affiliation(s)
- F. Pricci
- Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy
| | - M. Villa
- Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy
| | - F. Maccari
- Information Technology Service, Istituto Superiore di Sanità, Rome, Italy
| | - E. Agazio
- Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy
| | - D. Rotondi
- Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy
| | - P. Panei
- Grant Office and Technology Transfer, Istituto Superiore di Sanità, Rome, Italy
| | - P. Roazzi
- Health Technology Assessment, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
31
|
Bougatef H, Krichen F, Capitani F, Amor IB, Gargouri J, Maccari F, Mantovani V, Galeotti F, Volpi N, Bougatef A, Sila A. Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). Int J Biol Macromol 2019; 134:405-412. [PMID: 31071403 DOI: 10.1016/j.ijbiomac.2019.05.036] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2018] [Revised: 05/02/2019] [Accepted: 05/05/2019] [Indexed: 02/08/2023]
Abstract
Chondroitin sulfate/dermatan sulfate (CS/DS) were isolated and purified for the first time from the bone of corb (Sciaena umbra) (CBG) and their chemical composition and anticoagulant activity were assessed. Infrared spectrum and agarose-gel electrophoresis for extracted CS/DS were also investigated. The results showed that the purified CS/DS obtained at a yield of 10% contains about 31.28% sulfate and an average molecular mass of 23.35 kDa. Disaccharide analysis indicated that CBG was composed of monosulfated disaccharides in positions 6 and 4 of the N-acetylgalactosamine (8.6% and 40.0%, respectively) and disulfated disaccharides in different percentages. The charge density was 1.4 and the ratio of 4:6 sulfated residues was equal to 4.64. Chondroitinase AC showed that the purified CS/DS contained mainly 74% CS and 26% DS. Moreover, the new CS/DS extracted from bone of corb showed a strong anticoagulant effect through activated partial thrombosis time (aPTT), thrombin time (TT) and prothrombin time (PT). In fact, CBG prolonged significantly (p < 0.05), aPTT and PT about 2.62 and 1.26 fold, respectively, greater than that of the negative control at a concentration of 1000 μg/mL. However, TT assay of CBG was prolonged 3.53 fold compared with the control at 100 μg/mL. The purified CS/DS displayed a promising anticoagulant potential, which may be used as a novel and soothing drug.
Collapse
Affiliation(s)
- Hajer Bougatef
- Laboratory for the Improvement of Plants and Valorization of Agroresources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia
| | - Fatma Krichen
- Laboratory for the Improvement of Plants and Valorization of Agroresources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia
| | - Federica Capitani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Ikram Ben Amor
- Regional Centre for Blood Transfusion Sfax, El-Ain Road Km 0.5, P.C. 3003 Sfax, Tunisia
| | - Jalel Gargouri
- Regional Centre for Blood Transfusion Sfax, El-Ain Road Km 0.5, P.C. 3003 Sfax, Tunisia
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Veronica Mantovani
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Ali Bougatef
- Laboratory for the Improvement of Plants and Valorization of Agroresources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia
| | - Assaâd Sila
- Laboratory for the Improvement of Plants and Valorization of Agroresources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia; Department of Life Sciences, Faculty of Sciences of Gafsa, University of Gafsa, 2100 Gafsa, Tunisia.
| |
Collapse
|
32
|
Mahé E, Maccari F, Ruer-Mulard M, Bodak N, Barthelemy H, Nicolas C, Pépin E, Pillette-Delarue M, Buzenet C, Delaire PL, Nadaud M, Bouscarat F, Drouot-Lhoumeau D, Lepelley-Dupont C, Acher A, Beauchet A, Corgibet F. Psoriasis de l’enfant vu en milieu libéral : les aspects cliniques et épidémiologiques diffèrent des données habituellement publiées. Ann Dermatol Venereol 2019; 146:354-362. [PMID: 30954294 DOI: 10.1016/j.annder.2019.01.024] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Revised: 10/29/2018] [Accepted: 01/30/2019] [Indexed: 01/06/2023]
|
33
|
Phan C, Beauchet A, Burztejn A, Severino‐Freire M, Barbarot S, Girard C, Lasek A, Reguiai Z, Hadj‐Rabia S, Abasq C, Brenaut E, Droitcourt C, Perrussel M, Mallet S, Phan A, Lacour J, Khemis A, Bourrat E, Chaby G, Deborde R, Plantin P, Maruani A, Piram M, Maccari F, Fougerousse A, Kupfer‐Bessaguet I, Balguérie X, Barthelemy H, Martin L, Quiles‐Tsimaratos N, Mery‐Brossard L, Pallure V, Lons‐Danic D, Bouilly‐Auvray D, Beylot‐Barry M, Puzenat E, Aubin F, Mahé E. Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis. J Eur Acad Dermatol Venereol 2019; 33:1984-1992. [DOI: 10.1111/jdv.15579] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2018] [Accepted: 02/27/2019] [Indexed: 02/06/2023]
|
34
|
Maccari F, Fougerousse AC, Esteve E, Frumholtz L, Parier J, Hurabielle C, Cassius C, Taieb C. Crossed looks on the dermatologist's position and the patient's preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN-PSO study. J Eur Acad Dermatol Venereol 2019; 33:880-885. [PMID: 30633377 DOI: 10.1111/jdv.15423] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2018] [Accepted: 12/14/2018] [Indexed: 01/07/2023]
Abstract
BACKGROUND While some information on psoriasis impact on pregnancy is available, very little is known on the preoccupations of women afflicted by the disease or on the dermatologists' (D) positioning as to psoriasis and pregnancy. The 'Objectifs Peau' project demonstrated a 4.7% prevalence of psoriasis in women aged 18-45 years in France. OBJECTIVE This project sought to further address these issues in view of a targeted action plan. METHODS A questionnaire was made available to 361 D of different types. RESULTS Overall, 152 D answered the questionnaire, 50.7% working in private or mixed practice and 49.3% in hospitals, with 63% females (DF) and 37% males (DM). Over the last 3 months, the mean percentage of women of child-bearing age seen by these D was 28.6%. The main issue addressed by D upon psoriasis diagnosis was the patient's wish to become pregnant in the short-term (84%), while the compatibility of drug treatment with pregnancy was the issue prioritized by patients (64%). Among DM and DF, 46% and 29% reported having been confronted with an unplanned pregnancy, with their reaction mainly dependent on the treatment taken in 66%. Regarding follow-up, 26% D declared having shared their decision-making with gynaecologists, while 56% considered the first pregnancy trimester to be the highest-risk period. Only 28% D were familiar with existing recommendations, with only 21% of them considering them appropriate. CONCLUSION Overall, 26.2% of French psoriasis women are of child-bearing potential, in line with our dataset (28.6%). Only 56% D considered the 1st pregnancy trimester to be the highest-risk period, with only one-third familiar with existing recommendations. The gap between recommendations and actual practices must be addressed through policies that take women's preoccupations better into account.
Collapse
Affiliation(s)
- F Maccari
- Groupe d'Études Multicentriques ResoPso, La Varenne Saint-Hilaire, France
| | - A-C Fougerousse
- Groupe d'Études Multicentriques ResoPso, Bégin Military Teaching Hospital, Saint-Mandé, France
| | - E Esteve
- Groupe d'Études Multicentriques ResoPso, Orléans Regional Hospital Center, Orléans, France
| | - L Frumholtz
- Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France
| | - J Parier
- Groupe d'Études Multicentriques ResoPso, La Varenne Saint-Hilaire, France
| | - C Hurabielle
- Department of Dermatology and INSERM U976, Skin Research Institute, Saint-Louis Hospital, AP-HP, Paris, France
| | - C Cassius
- Department of Dermatology and INSERM U976, Skin Research Institute, Saint-Louis Hospital, AP-HP, Paris, France
| | - C Taieb
- Scientific direction, European Market Maintenance Assessment, Fontenay-sous-Bois, France.,Public Health, Hôpital Necker Enfants Malades, AP-HP, Paris, France
| | | |
Collapse
|
35
|
Tournier A, Khemis A, Maccari F, Reguiai Z, Bégon E, Fougerousse AC, Amy de la Breteque M, Beneton N, Parier J, Boyé T, Avenel-Audran M, Girard C, Pallure V, Perrot JL, Bastien M, Mahé E, Beauchet A. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France. Ann Dermatol Venereol 2019; 146:106-114. [DOI: 10.1016/j.annder.2018.11.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2018] [Revised: 08/28/2018] [Accepted: 11/21/2018] [Indexed: 12/28/2022]
|
36
|
Volpi N, Maccari F, Galeotti F, Peila C, Coscia A, Zampini L, Monachesi C, Gabrielli O, Coppa G. Human milk glycosaminoglycan composition from women of different countries: a pilot study. J Matern Fetal Neonatal Med 2019; 33:2131-2133. [PMID: 30348026 DOI: 10.1080/14767058.2018.1539309] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Objective: In this pilot study, we report the composition, structure and properties of glycosaminoglycans (GAG) present in milk samples of various countries and ethnicities.Methods: Fifty samples of human milk were analyzed, 10 from east Europe, 10 from North Africa, 10 from Central Africa, 10 from South America and 10 from Asia. Moreover, 30 samples were obtained during the first week and 20 between 8 to 30 days of life.Results: Overall, no significant differences were observed for the qualitative composition of GAGs, mainly chondroitin sulfate, heparan sulfate and hyaluronic acid, comparing the mothers from the various countries and between the 30 milks obtained during the first week and the 20 samples collected thereafter. Moreover, no significant differences in human milk GAGs within the different groups analyzed belonging to various counties and ethnicities were observed.Conclusions: These results may be of useful, as in the case of pilot studies with infant formulas enriched with chondroitin sulfate (CS) and/or heparan sulfate (HS) necessary to verify their possible positive effects on newborns feeding in countries at high risk of infection and/or infestation.
Collapse
Affiliation(s)
- Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Chiara Peila
- Department of Public Health and Pediatric, Neonatal Unit, University of Turin, Turin, Italy
| | - Alessandra Coscia
- Department of Public Health and Pediatric, Neonatal Unit, University of Turin, Turin, Italy
| | - Lucia Zampini
- Department of Clinical Sciences, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy
| | - Chiara Monachesi
- Department of Clinical Sciences, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy
| | - Orazio Gabrielli
- Department of Clinical Sciences, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy
| | - Giovanni Coppa
- Department of Clinical Sciences, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy
| |
Collapse
|
37
|
Fougerousse A, Guillem P, Allal S, Maccari F, Beneton N, Binois R, Cinotti E, Cambazard F, Perrot JL. Influence de l’ancienneté de la maladie de Verneuil sur la qualité de vie et la douleur à propos de 1428 sujets : étude EpiVer. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Halioua B, Maccari F, Fougerousse A, Parier J, Reguiai Z, Taieb C, Esteve E. Évaluation du retentissement du psoriasis chez les conjoints à l’aide de FamilyPso. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Amy de la Breteque M, Beauchet A, Maccari F, Ruer-Mulard M, Bastien M, Chaby G, Le Guyadec T, Estève E, Parier J, Dauendorffer JN, Barthelemy H, Gener G, Wagner L, Pfister P, Bégon E, Mery-Brossard L, Schmutz JL, Mahé E. Les patients psoriasiques vus en cabinet libéral et à l’hôpital sont-ils différents ? Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
40
|
Maccari F, Fougerousse A, Esteve E, Frumholtz L, Parier J, Hurabielle C, Cassius C, Taieb C. Psoriasis et grossesse : regards croisés entre position du dermatologue et préoccupations des patientes. Premiers résultats de l’étude GESTA-PSO. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Halioua B, Maccari F, Fougerousse A, Parier J, Reguiai Z, Taieb C, Esteve E. Dysfonctionnements sexuels chez le conjoint de patients souffrant de psoriasis. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
42
|
Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, Nielsen J. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma. Eur Urol Oncol 2018; 1:364-377. [PMID: 31158075 PMCID: PMC8253162 DOI: 10.1016/j.euo.2018.04.015] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Revised: 04/11/2018] [Accepted: 04/26/2018] [Indexed: 12/11/2022]
Abstract
BACKGROUND Plasma glycosaminoglycan (GAG) measurements, when aggregated into diagnostic scores, accurately distinguish metastatic clear-cell renal cell carcinoma (RCC) from healthy samples and correlate with prognosis. However, it is unknown if GAG scores can detect RCC in earlier stages or if they correlate with prognosis after surgery. OBJECTIVE To explore the sensitivity and specificity of plasma GAGs for detection of early-stage RCC and prediction of recurrence and death after RCC surgery. DESIGN, SETTING, AND PARTICIPANTS This was a retrospective case-control study consisting of a consecutive series of 175 RCC patients surgically treated between May 2011 and February 2014 and 19 healthy controls. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS Plasma GAGs in preoperative and postoperative RCC and healthy samples were measured using capillary electrophoresis with laser-induced fluorescence in a single blinded laboratory. A discovery set was first analyzed to update the historical GAG score. The sensitivity of the new GAG score for RCC detection versus healthy subjects was validated using the remaining samples. The correlation of the new GAG score to histopathologic variables, overall survival, and recurrence-free survival was evaluated using nonparametric and log-rank tests and multivariable Cox regression analyses. RESULTS AND LIMITATIONS The RCC cohort included 94 stage I, 58 stage II-III, and 22 stage IV cases. In the first discovery set (n=67), the new GAG score distinguished RCC from healthy samples with an area under the receiver operating characteristic curve (AUC) of 0.999. In the validation set (n=108), the GAG score achieved an AUC of 0.991, with 93.5% sensitivity. GAG scores were elevated in RCC compared to healthy samples, irrespective of and uncorrelated to stage, grade, histology, age, or gender. The total chondroitin sulfate concentration was an independent prognostic factor for both overall and recurrence-free survival (hazard ratios 1.51 and 1.25) with high concordance when combined with variables available at pathologic diagnosis (C-index 0.926 and 0.849) or preoperatively (C-index 0.846 and 0.736). Limitations of the study include its retrospective nature and moderate variability in GAG laboratory measurements. CONCLUSIONS Plasma GAGs are highly sensitive diagnostic and prognostic biomarkers in surgically treated RCC independent of stage, grade, or histology. Prospective validation studies on GAG scores for early detection, prediction, and surveillance for RCC recurrence are thus warranted. PATIENT SUMMARY In this study, we examined if a new molecular blood test can detect renal cell carcinoma in the early stages and predict if the cancer might relapse after surgery. The trial is registered on ClinicalTrial.gov as NCT03471897.
Collapse
Affiliation(s)
- Francesco Gatto
- Department of Biology and Biological Engineering, Chalmers University of Technology, Göteborg, Sweden
| | - Kyle A Blum
- Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | - Mazyar Ghanaat
- Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Mahyar Kashan
- Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - James J Hsieh
- Department of Medicine, Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - A Ari Hakimi
- Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Jens Nielsen
- Department of Biology and Biological Engineering, Chalmers University of Technology, Göteborg, Sweden.
| |
Collapse
|
43
|
Bougatef H, Krichen F, Capitani F, Amor IB, Maccari F, Mantovani V, Galeotti F, Volpi N, Bougatef A, Sila A. Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect. Carbohydr Polym 2018; 196:272-278. [DOI: 10.1016/j.carbpol.2018.05.019] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2018] [Revised: 04/18/2018] [Accepted: 05/06/2018] [Indexed: 01/17/2023]
|
44
|
Krichen F, Bougatef H, Sayari N, Capitani F, Ben Amor I, Koubaa I, Maccari F, Mantovani V, Galeotti F, Volpi N, Bougatef A. Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties. Carbohydr Polym 2018; 197:451-459. [PMID: 30007634 DOI: 10.1016/j.carbpol.2018.06.040] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 05/25/2018] [Accepted: 06/07/2018] [Indexed: 01/02/2023]
Abstract
Chondroitin sulfate was extracted from the cartilage of smooth hound (CSSH) and then purified by anion exchange chromatography. The structual characteristic of CSSH was evaluated by acetate cellulose electrophoresis, FTIR, 13C NMR and SAX-HPLC. Molecular weight of CSSH was average 68.78 KDa. Disaccharide analysis indicated that CSSH was predominately composed of monosulfated disaccharides in position 6 and 4 of the N-acetylgalactosamine (45.34% and 32.49%, respectively). CSSH was tested for in vitro anticoagulant activity using the three classical coagulation assays (activated partial thromboplastin time (aPTT), prothrombine time (TT) and thrombin time (PT) tests). The finding showed that CSSH prolonged significatively (p < 0.05), aPTT, TT and PT about 1.4, 3.44 and 1.21 fold, respectively, greater than that of the negative control at a concentration of 100 μg/ml. The CSSH caused a significant antiproliferative activity against HCT116 cell, which was 79% of cell proliferation inhibition at the concentration of 1000 μg/ml. Further, CSSH presented no toxicity against the normal cells and no hemolysis towards bovine erythrocytes for all concentrations tested. CSSH demonstrated hopeful antiproliferative and anticoagulant potential, which may be used as a novel and effective drug.
Collapse
Affiliation(s)
- Fatma Krichen
- Laboratory of Plant Improvement and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia
| | - Hajer Bougatef
- Laboratory of Plant Improvement and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia
| | - Nadhem Sayari
- Laboratory of Plant Improvement and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia
| | - Federica Capitani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Ikram Ben Amor
- Regional Centre for Blood Transfusion in Sfax, El-Ain Road Km 0.5, CP 3003 Sfax, Tunisia
| | - Imed Koubaa
- Faculty of Science of Sfax, Laboratory of Chemistry of Natural Products, University of Sfax, Tunisia
| | - Francesca Maccari
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Veronica Mantovani
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Fabio Galeotti
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Nicola Volpi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Ali Bougatef
- Laboratory of Plant Improvement and Valorization of Agroressources, National School of Engineering of Sfax (ENIS), University of Sfax, Sfax 3038, Tunisia.
| |
Collapse
|
45
|
Blum KA, Gatto F, Ghannat M, Sanchez A, Maccari F, Galeotti F, Hsieh J, Volpi N, Hakimi AA, Nielsen J. MP72-19 PLASMA GLYCOSAMINOGLYCAN SCORES IN RENAL CELL CARCINOMA. J Urol 2018. [DOI: 10.1016/j.juro.2018.02.2303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
46
|
Krichen F, Bougatef H, Capitani F, Ben Amor I, Koubaa I, Gargouri J, Maccari F, Mantovani V, Galeotti F, Volpi N, Bougatef A. Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities. RSC Adv 2018; 8:37965-37975. [PMID: 35558578 PMCID: PMC9089755 DOI: 10.1039/c8ra06704j] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Accepted: 10/28/2018] [Indexed: 11/21/2022] Open
Abstract
Chondroitin sulfate/dermatan sulfate (CS/DS) was extracted from Atlantic bluefin tuna (Thunnus thynnus) skin (SGAT) and was purified and characterized. SGAT was characterized by acetate cellulose electrophoresis, FTIR spectroscopy, 13C NMR spectroscopy and SAX-HPLC. According to the results obtained for specific chondroitinases (ABC and AC) and the SAX-HPLC separation of generated unsaturated repeating disaccharides, the polymer was found to contain a disaccharide monosulfated in positions 6 and 4 of GalNAc and disulfated disaccharides in different percentages. These results were confirmed by 13C NMR experiments. The average molecular mass was 24.07 kDa, as determined by PAGE analysis. SGAT was evaluated for its in vitro anticoagulant activity via activated partial thromboplastin time, thrombin time and prothrombin time tests. The polymer showed strong inhibitory activity against angiotensin I-converting enzyme (IC50 = 0.25 mg mL−1). Overall, the results suggest that this newly extracted CS/DS can be useful for pharmacological applications. Chondroitin sulfate/dermatan sulfate (CS/DS) was extracted from Atlantic bluefin tuna (Thunnus thynnus) skin (SGAT) and was purified and characterized.![]()
Collapse
|
47
|
Mahé E, Beauchet A, Fougerousse AC, Becherel PA, Begon E, Chaby G, Bravard P, Quiles-Tsimaratos N, Avenel-Audran M, Poiraud C, Mery-Brossard L, Lons-Danic D, Jacobzone C, Pauwels C, Kupfer-Bessaguet I, Amy de la Breteque M, Maccari F, Sigal ML. Influence des caractéristiques des patients sur le choix d’une biothérapie (anti-TNF-alpha vs anti-Il 12/23) pour un psoriasis. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
48
|
Ariane M, Estève E, Fougerousse AC, Avenel-Audran M, Quiles-Tsimaratos N, Mery-Brossard L, Pauwels C, Le Guyadec T, Bastien M, Liégeon AL, Pallure V, Girard C, Alexandre M, Khatibi B, Poiraud C, Maccari F, Amy de la Breteque M, Sigal ML, Beauchet A, Mahé E. Utilisation de régimes d’éviction et médecines alternatives chez les patients atteints de psoriasis : une enquête nationale. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
Allal S, Guillem P, Fougerousse A, Beneton N, Maccari F, Labeille B, Tisseran E, Vuering F, Vergote-Pelamourgues S, Cinotti E, Perrot JL. Données démographiques et biométriques de 882 sujets atteints de maladie de Verneuil : EpiVer étude multicentrique française ville-hôpital. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
50
|
Mantovani V, Galeotti F, Maccari F, Volpi N. Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides, and polysaccharides. Electrophoresis 2017; 39:179-189. [DOI: 10.1002/elps.201700290] [Citation(s) in RCA: 71] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2017] [Revised: 08/22/2017] [Accepted: 08/23/2017] [Indexed: 01/26/2023]
Affiliation(s)
- Veronica Mantovani
- Department of Life Sciences; University of Modena and Reggio Emilia; Modena Italy
| | - Fabio Galeotti
- Department of Life Sciences; University of Modena and Reggio Emilia; Modena Italy
| | - Francesca Maccari
- Department of Life Sciences; University of Modena and Reggio Emilia; Modena Italy
| | - Nicola Volpi
- Department of Life Sciences; University of Modena and Reggio Emilia; Modena Italy
| |
Collapse
|